Autopsy report · NCT05703854
Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma
Cause of deathOther
“PI Request”
Life of this trial
- Registered 2 months before it started.
- Suspended: paused, and may or may not restart.
- 50 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 1, Phase 2
- Sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Advanced Renal Cell Carcinoma; Advanced Mesothelioma; Advanced Osteosarcoma
- Interventions
- CAR.70/IL15-transduced CB-derived NK cells; Fludarabine phosphate; Cyclophosphamide
- Participants
- 50 (planned, not actual)
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.